OpenAlex
PricingAboutJobs
Log inGet started
Work

Abstract A37: Translational biomarkers for cancer drug response: Cell line panel derived drug response signature predicts patients’ survival in a lung cancer clinic trial.

HTML

Year: 2013
Type: conference-abstract
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.targ-13-a37
Authors: Bin Li, Hyunjin Shin, Georgy Gulbekyan, Olga Pustovalova, Yuri Nikolsky, Andrew Hope, Marina Bessarabova, Matthew Schu, William Trepicchio
Institution: Thomson Reuters (United States)
Language: English

Topic: Lung Cancer Treatments and Mutations
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: translational biomarkers, drug response prediction, lung cancer, erlotinib, sorafenib, cell line panel, partial least squares regression, predictive gene signature, progression-free survival, drug resistance, patient stratification, IC50, targeted therapy response, non-small cell lung cancer
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2318705335
Cites:
Cited by:
Related to: 9
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security